Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Frontier Group Holdings
ULCC
$1.5B
| $130K | ﹤0.01% |
23,782
-21
| -0.1% | -$92 |
|
2502
Domo
DOMO
$171M
| $128K | ﹤0.01% |
12,442
-21
| -0.2% | -$194 |
|
2503
Sana Biotechnology
SANA
$882M
| $123K | ﹤0.01% |
30,167
-11
| -0% | -$41 |
|
2504
Petco
WOOF
$797M
| $122K | ﹤0.01% |
38,679
-70
| -0.2% | -$242 |
|
2505
Mama's Creations
MAMA
$846M
| $121K | ﹤0.01% |
+24,698
| New | +$97.4K |
|
2506
Invesco Mortgage Capital
IVR
$759M
| $121K | ﹤0.01% |
13,665
-15
| -0.1% | -$122 |
|
2507
ARS Pharmaceuticals
SPRY
$579M
| $120K | ﹤0.01% |
21,809
-74
| -0.3% | -$324 |
|
2508
Tango Therapeutics
TNGX
$4.21B
| $118K | ﹤0.01% |
11,908
+3
| +0% | +$26 |
|
|
SFIX
2509
Stitch Fix
SFIX
$566M
| $118K | ﹤0.01% |
32,878
-42
| -0.1% | -$148 |
|
2510
Allogene Therapeutics
ALLO
$625M
| $117K | ﹤0.01% |
36,498
+25
| +0.1% | +$71 |
|
2511
Hallador Energy
HNRG
$646M
| $116K | ﹤0.01% |
+13,114
| New | +$165K |
|
|
SHCR
2512
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $115K | ﹤0.01% |
106,150
-249
| -0.2% | -$255 |
|
2513
NextDecade
NEXT
$1.68B
| $113K | ﹤0.01% |
23,731
-529
| -2% | -$2.46K |
|
2514
SIGA Technologies
SIGA
$240M
| $111K | ﹤0.01% |
19,784
-36
| -0.2% | -$193 |
|
2515
1-800-Flowers.com
FLWS
$252M
| $110K | ﹤0.01% |
10,182
-24
| -0.2% | -$205 |
|
2516
PLAYSTUDIOS Inc
MYPS
$76.2M
| $106K | ﹤0.01% |
39,154
-65
| -0.2% | -$177 |
|
2517
Ribbon Communications
RBBN
$386M
| $106K | ﹤0.01% |
36,342
-115
| -0.3% | -$259 |
|
|
SACH
2518
Sachem Capital Corp
SACH
$37.1M
| $105K | ﹤0.01% |
+27,973
| New | +$99.9K |
|
|
CTEV
2519
Claritev Corp
CTEV
$399M
| $104K | ﹤0.01% |
1,805
-5
| -0.3% | -$304 |
|
2520
Ranpak Holdings
PACK
$500M
| $98.1K | ﹤0.01% |
16,856
-64
| -0.4% | -$270 |
|
2521
Cogent Biosciences
COGT
$6.76B
| $95.9K | ﹤0.01% |
16,292
-1,620,669
| -99% | -$12.4M |
|
2522
Funko
FNKO
$346M
| $95.7K | ﹤0.01% |
12,389
-40
| -0.3% | -$289 |
|
|
VLD
2523
DELISTED
Velo3D, Inc.
VLD
| $93.3K | ﹤0.01% |
6,704
+520
| +8% | +$20K |
|
|
VTNR
2524
DELISTED
Vertex Energy, Inc
VTNR
| $93.3K | ﹤0.01% |
27,398
-71
| -0.3% | -$279 |
|
|
WOW
2525
DELISTED
WideOpenWest
WOW
| $91.8K | ﹤0.01% |
22,692
-48
| -0.2% | -$258 |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.